Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer

Eitemau Tebyg

• Fluciclovine (F-18) is a marker for high-affinity glutamine transporter ASCT2-mediated amino acid transport in breast cancer
  gan: Teoh, E, et al.
  Cyhoeddwyd: (2017)
• Characterising ¹⁸F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging
  gan: Scott, NP, et al.
  Cyhoeddwyd: (2021)
• Cancer imaging with fluciclovine (18F)
  gan: Teoh, E
  Cyhoeddwyd: (2018)
• Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer
  gan: Morotti, M, et al.
  Cyhoeddwyd: (2020)
• Glutamine deprivation alters the origin and function of cancer cell exosomes
  gan: Fan, S, et al.
  Cyhoeddwyd: (2020)